FDA Drug Safety Intelligence
Under maintenancePricing
Pay per usage
FDA Drug Safety Intelligence
Under maintenanceCross-reference FDA databases for drug product info, adverse events, and recalls. Normalizes 200+ brand/generic drug names with manufacturer deduplication. Free API, no key needed.
Pricing
Pay per usage
Rating
0.0
(0)
Developer
Chris Wakefield
Maintained by CommunityActor stats
0
Bookmarked
1
Total users
0
Monthly active users
5 days ago
Last modified
Share

FDA Drug Safety Intelligence π₯
Cross-reference multiple FDA databases to build comprehensive drug safety profiles. Searches drug product labeling (NDC directory), adverse event reports (FAERS), and enforcement actions (recalls) β then normalizes brand/generic drug names and manufacturer data for clean, analyzable output.
Features
- π Multi-endpoint intelligence β Products, adverse events, and recalls in one run
- π·οΈ 200+ drug name normalizations β Brandβgeneric mapping (OzempicβSemaglutide, LipitorβAtorvastatin, etc.)
- π Manufacturer deduplication β Canonical names for 50+ pharma companies
- β οΈ Recall severity classification β Class I/II/III with risk indicators
- π Human-readable summary β Formatted table output with reaction frequency bars
- π No API key required β OpenFDA is free and public
Input
| Field | Type | Description |
|---|---|---|
searchQuery | string | Brand or generic drug name (e.g. ozempic, semaglutide, ibuprofen) |
searchType | enum | full (all), products_only, events_only, recalls_only |
maxResults | integer | Max results per endpoint (1β1000, default 100) |
seriousOnly | boolean | Only return serious adverse events |
Example Input
{"searchQuery": "ozempic","searchType": "full","maxResults": 50,"seriousOnly": false}
Example Output
================================================================================FDA DRUG SAFETY INTELLIGENCE REPORT================================================================================Search Query: ozempicNormalized: Semaglutideββ PRODUCT INFORMATION (7 unique) ββ1. Ozempic (semaglutide)Mfr: Novo Nordisk | NDC: 0169-1305 | Form: INJECTION, SOLUTION2. Ozempic (semaglutide)Mfr: Novo Nordisk | NDC: 0169-1310 | Form: INJECTION, SOLUTIONββ ADVERSE EVENTS (50 reports) ββSerious: 34 (68%) | Deaths: 2 | Hospitalizations: 18Top Reactions:Nausea 12 ββββββββββββββββββββββββVomiting 8 ββββββββββββββββPancreatitis 5 ββββββββββ...ββ RECALLS (1 found) ββHigh Risk (Class I): 11. [HIGH] Ozempic (semaglutide) injectionFirm: Novo Nordisk | Date: 20240315 | Status: Ongoing
Use Cases
- Pharmaceutical competitive intelligence β Track adverse event profiles of competitor drugs
- Clinical safety research β Analyze real-world drug safety signals from FAERS
- Healthcare compliance β Monitor FDA enforcement actions and recalls
- Legal / liability β Gather drug safety evidence for litigation
- AI / ML pipelines β Feed normalized drug safety data into predictive models
Data Sources
All data comes from the OpenFDA public API (public domain, no license restrictions):
- Drug Product Labeling (
drug/ndc.json) β 137K+ products - Adverse Event Reports (
drug/event.json) β 20M+ FAERS reports - Drug Enforcement Actions (
drug/enforcement.json) β Recalls, market withdrawals
Pricing
Pay-per-result pricing via the Apify platform. Each dataset item after the free tier counts as one event.
Built by Chris The Dev β’ Data: open.fda.gov (public domain)